Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07362017 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis

Name: Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis — clinical trial record (NCT07362017)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 3

SponsorVanda Pharmaceuticals

Started2026-02-17

View on ClinicalTrials.gov ↗

Amendment history

2026-09-23

Trial sites expanded: 4 → 10 locations

2026-06-10

Study Status, Contacts/Locations v1

Recruitment opened

Trial sites expanded: 0 → 4 locations

Start dateestimated 2026-01→confirmed 2026-02-17

2026-01-21

Original filing

Vanda Pharmaceuticals

23 trials monitored

See 3 trials at risk

Psoriasis

418 trials monitored

See 17 trials at risk

An open label study to investigate the safety and efficacy of ponesimod in participants with moderate-to-severe chronic plaque psoriasis

Trial Details

NCT Number	NCT07362017
Lead Sponsor	Vanda Pharmaceuticals
Conditions	Moderate-to-severe Chronic Plaque Psoriasis
Enrollment	300 participants
Start Date	2026-02-17
Primary Completion	2028-08 (estimated)
Study Completion	2028-12 (estimated)
Updated on ClinicalTrials.gov	2026-09-22